Cite Filings / CCCC / 0001628280-24-044411

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

C4 Therapeutics, Inc. Filed 2024-10-31 Acc 0001628280-24-044411

Documents 1

10-Q Quarterly Report , cccc-20240930.htm

Around this filing

2025-05-07 10-Q Quarterly Report
2024-10-31 S-3 Registration Statement
2024-10-31 S-3 Registration Statement
2024-10-31 10-Q Quarterly Report
2024-10-31 8-K Results of operations
2024-10-29 4 Chief Scientific Officer acquired 76,800 shares (grant or award)
2024-08-01 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading cccc-20240930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…